Danaher Taps Julie Sawyer Montgomery as CEO, Rainer Blair to Retire; Board Greenlights Over $43M in Special Equity Awards for Leadership
DHR sits 27% above its 52-week low of $160.93.
Summary
Danaher appointed Julie Sawyer Montgomery as its next CEO, replacing Rainer Blair, who will retire. To retain leadership through a multi-year growth phase, the board approved over $43 million in special equity awards for the new CEO, founders, and other top executives.
Key Events · Executive and Board Changes · DHR
-
CEO Succession Announced
Effective October 1, 2026, Julie Sawyer Montgomery — currently EVP of Diagnostics — will step into the role of President and CEO. She succeeds Rainer Blair, who will retire and serve as Senior Advisor through March 2027.
-
New CEO Compensation Package
Montgomery's compensation includes a $1.5M base salary, a 200% target bonus, a 2027 equity award target of $13.2M, and a one-time $20M stock option award that vests 50% at year 4 and 50% at year 5.
-
Founder Retention Awards
To align their interests with long-term shareholder value, Chairman Steven Rales and Executive Committee Chairman Mitchell Rales each received 1M stock options and 500K restricted stock units, vesting over 4–5 years.
-
Other Executive Equity Grants
CFO Matthew Gugino received a $12.5M option award; EVP Christopher Riley received $8M in RSUs; and CSO Jose-Carlos Gutierrez-Ramos received $2.625M in RSUs. All awards carry multi-year vesting.
Analysis · DHR · Industrial Applications And Services
Danaher is executing a planned CEO succession, elevating insider Julie Sawyer Montgomery to the top role effective October 1. To ensure a smooth handoff, outgoing CEO Rainer Blair will stay on as an advisor through March 2027. Simultaneously, the board is granting a large, multi-year equity retention package to the new CEO, the founders, and other key executives — a clear signal that leadership is being locked in for the next phase of growth following the transformative Masimo acquisition. The awards carry long vesting periods of 4–5 years and are tied to continued employment, aligning management with shareholders. With the company reaffirming its existing guidance, no operational surprises accompany the change.
At the time of this filing, DHR was trading at $203.77 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $138.8B. The 52-week trading range was $160.93 to $242.80. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.